CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Amgen Inc 's Working Capital Ratio

AMGN's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




AMGN Working Capital Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Change 8.81 % -9.21 % -7.3 % -0.93 % -6.92 %
Y / Y Current Assets Change 13.21 % 14.66 % -27.02 % -25.54 % -46.48 %
Working Capital Ratio MRQ 1.66 1.81 2.28 2.18 1.59
Overall Ranking # # # # #
Seq. Current Liabilities Change 10.44 % 17.08 % -5.42 % -11.03 % -7.85 %
Seq. Current Assets Change 0.73 % -6.69 % -1.02 % 21.7 % 2.02 %



Working Capital Ratio first quarter 2021 Comment
Due to increase in Current Liabilities in the first quarter 2021, Working Capital Ratio fell to 1.66 below Amgen Inc average.

Within Biotechnology & Drugs industry 195 other companies have achieved higher Working Capital Ratio than Amgen Inc in first quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is AMGN most successful ?
Working Capital Ratio AMGN on the trailing twelve month basis
Working Capital Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 196
Healthcare Sector # 770
Overall Market # 2952


Working Capital Ratio Statistics
High Average Low
6.33 3.44 1.31
(Sep. 30, 2013)   (Sep. 30, 2004)




Financial Statements
Amgen Inc 's Current Liabilities $ 12,869 Millions Visit AMGN's Balance sheet
Amgen Inc 's Current Assets $ 21,299 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMar 31 2021, within Biotechnology & Drugs Industry Working Capital RatioMar 31 2021 MRQ Current AssetsMar 31 2021 MRQ Current Liabilities
Apollo Endosurgery inc   4.44 $ 55.892  Millions$ 12.595  Millions
Enochian Biosciences Inc  4.39 $ 4.921  Millions$ 1.121  Millions
Fulgent Genetics Inc   4.38 $ 659.140  Millions$ 150.521  Millions
Compass Therapeutics Inc   4.24 $ 41.647  Millions$ 9.825  Millions
Brickell Biotech Inc   4.16 $ 38.778  Millions$ 9.329  Millions
Bio techne Corp  4.12 $ 566.606  Millions$ 137.640  Millions
Axon Enterprise inc   4.11 $ 986.229  Millions$ 239.775  Millions
Cytomx Therapeutics Inc   4.08 $ 400.008  Millions$ 98.049  Millions
Galera Therapeutics Inc   4.05 $ 64.240  Millions$ 15.855  Millions
Wave Life Sciences Ltd   4.00 $ 194.545  Millions$ 48.680  Millions
Cytrx Corp  3.77 $ 10.033  Millions$ 2.662  Millions
Meridian Bioscience Inc   3.74 $ 188.294  Millions$ 50.310  Millions
Cel sci Corporation  3.70 $ 21.538  Millions$ 5.823  Millions
Cannabics Pharmaceuticals Inc   3.56 $ 4.217  Millions$ 1.184  Millions
Quidel Corporation  3.50 $ 1,282.713  Millions$ 366.936  Millions
Procyon Corp  3.47 $ 2.097  Millions$ 0.605  Millions
Chromadex Corporation  3.20 $ 63.219  Millions$ 19.756  Millions
Emergent Biosolutions Inc   3.19 $ 1,181.100  Millions$ 370.200  Millions
Beauty Health Co  3.18 $ 3.349  Millions$ 1.054  Millions
Aerie Pharmaceuticals Inc   3.14 $ 293.577  Millions$ 93.364  Millions
Repligen Corp  2.99 $ 926.335  Millions$ 309.558  Millions
Vir Biotechnology Inc   2.75 $ 993.114  Millions$ 361.099  Millions
Biocryst Pharmaceuticals Inc  2.71 $ 273.771  Millions$ 101.201  Millions
Cyanotech Corp  2.60 $ 15.106  Millions$ 5.808  Millions
Pactiv Evergreen Inc   2.45 $ 1,768.000  Millions$ 721.000  Millions
Quotient Limited  2.45 $ 143.876  Millions$ 58.829  Millions
Coherus Biosciences inc   2.40 $ 617.261  Millions$ 257.601  Millions
Iterum Therapeutics Plc  2.39 $ 104.233  Millions$ 43.619  Millions
Reynolds Consumer Products Inc   2.29 $ 971.000  Millions$ 424.000  Millions
Myriad Genetics Inc   2.21 $ 329.200  Millions$ 149.000  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BUKX's Profile

Stock Price

BUKX's Financials

Business Description

Fundamentals

Charts & Quotes

BUKX's News

Suppliers

BUKX's Competitors

Customers & Markets

Economic Indicators

BUKX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071